BOK Financial’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17 | Sell |
1
-2,694
| -100% | -$45.8K | ﹤0.01% | 1145 |
|
|
2025
Q1 | $172K | Sell |
2,695
-9,297
| -78% | -$593K | ﹤0.01% | 717 |
|
|
2024
Q4 | $1.5M | Buy |
11,992
+11,990
| +599,500% | +$1.5M | 0.03% | 389 |
|
|
2024
Q3 | $238 | Hold |
2
| – | – | ﹤0.01% | 1327 |
|
|
2024
Q2 | $316 | Sell |
2
-14
| -88% | -$2.21K | ﹤0.01% | 1126 |
|
|
2024
Q1 | $2.05K | Buy |
16
+14
| +700% | +$1.8K | ﹤0.01% | 1060 |
|
|
2023
Q4 | $192 | Sell |
2
-12
| -86% | -$1.15K | ﹤0.01% | 1239 |
|
|
2023
Q3 | $942 | Buy |
+14
| New | +$942 | ﹤0.01% | 1090 |
|
|
2023
Q2 | – | Sell |
-132
| Closed | -$18.2K | – | 1169 |
|
|
2023
Q1 | $18.2K | Buy |
+132
| New | +$18.2K | ﹤0.01% | 937 |
|
|
2021
Q1 | – | Sell |
-29,288
| Closed | -$4.99M | – | 949 |
|
|
2020
Q4 | $4.99M | Buy |
29,288
+9,114
| +45% | +$1.55M | 0.1% | 204 |
|
|
2020
Q3 | $2.83M | Sell |
20,174
-3,048
| -13% | -$428K | 0.06% | 265 |
|
|
2020
Q2 | $3.72M | Sell |
23,222
-1,013
| -4% | -$162K | 0.09% | 218 |
|
|
2020
Q1 | $2.37M | Buy |
24,235
+5,078
| +27% | +$497K | 0.07% | 260 |
|
|
2019
Q4 | $2.47M | Buy |
+19,157
| New | +$2.47M | 0.06% | 311 |
|
|
2019
Q3 | – | Sell |
-26,415
| Closed | -$4.01M | – | 942 |
|
|
2019
Q2 | $4.01M | Buy |
26,415
+4,694
| +22% | +$713K | 0.1% | 226 |
|
|
2019
Q1 | $2.59M | Buy |
21,721
+19,035
| +709% | +$2.27M | 0.06% | 300 |
|
|
2018
Q4 | $293K | Sell |
2,686
-11,045
| -80% | -$1.2M | 0.01% | 741 |
|
|
2018
Q3 | $2.22M | Buy |
+13,731
| New | +$2.22M | 0.06% | 351 |
|
|
2018
Q1 | – | Sell |
-42,631
| Closed | -$2.37M | – | 944 |
|
|
2017
Q4 | $2.37M | Buy |
42,631
+7,659
| +22% | +$426K | 0.07% | 315 |
|
|
2017
Q3 | $1.59M | Buy |
+34,972
| New | +$1.59M | 0.05% | 384 |
|